Ass.Prof. Mag. Andrea De Luna, PhD

Donau-Universität Krems

Andrea De Luna

Ass.Prof. Mag. Andrea De Luna, PhD

Post-Doc - Zentrum für Regenerative Medizin

Projekte (Auszug Forschungs­datenbank)

Publikationen (Auszug Forschungs­datenbank)

De Luna-Preitschopf, A.; Zwickl, H.; Nehrer, S.; Hengstschläger, M.; Mikula, M. (2017). Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes. International Journal of Molecular Sciences, 18(7): doi:10.3390/ijms18071494

Kuten, O.; Simon, M.; Hornyák, I.; De Luna-Preitschopf, A.; Nehrer, S.; Lacza, Z. (2017). The Effects of Hyperacute Serum on Adipogenesis and Cell Proliferation of Mesenchymal Stromal Cells. Tissue Engineering Part A, Vol. 24, No. 11-12: doi: 10.1089/ten.TEA.2017.0384

Preitschopf, A.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Zwickl, H.; Rosner, M.; Joó, J.G.; Nehrer, S; Hengstschläger, M; Mikula, M. (2016). Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells. Stem Cells Translational Medicine: 580-90

Schörghofer, D.; Kinslechner, K.; Preitschopf, A.; Schütz, B.; Röhrl, C.; Hengstschläger, M.; Stangl, H.; Mikula, M. (2015). The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence. Reprod Biol Endocrinol, Vol. 13, No. 88

Üstün, S.; Lassnig, C.; Preitschopf, A.; Mikula, M.; Müller, M.; Hengstschläger, M.; Weichhart, T. (2015). Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transpl Immunol.

Üstün, S.; Lassnig, C.; Preitschopf, A.; Mikula, M.; Müller, M.; Hengstschläger, M.; Weichhart, T. (2015). Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transplantation Immunology: 45-50

Preitschopf, A.; Zwickl, H.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Rosner, M.; Joo, G.J.; Hengstschläger, M.; Nehrer, S.; Mikula, M. (2015). Rapamycin enhances Sox9 Expression during Chondrogenic Differentiation of Amniotic Fluid Stem Cells. Tissue Engineering Part A, September 2015, Volume 21, Supplement 1: 192

Preitschopf, A.; Zwickl, H.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Rosner, M.; Joó, J.; Hengstschläger, M.; Nehrer, S.; Mikula, M. (2015). Rapamycin enhances SOX9 expression during chondrogenic differentiation of amniotic fluid stem cells. Tissue Engineering Part A: 192-93

Preitschopf, A.; Li, K.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Thi Thanh Pham, H.; Rosner, M.; Joo, G.; Röhrl, C.; Weichhart, T.; Stangl, H.; Lubec, G.; Hengstschläger, M.; Mikula, M. (2014). mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression. Plos One

Preitschopf, A.; Busch, J.; Zwickl, H.; Nehrer, S.; Hengstschläger, M.; Mikula, M. (2014). Amniotic Fluid Stem Cells for the Treatment of Articular Cartilage Defects. In: Perinatal Stem Cells: 87-98, Springer Verlag

Mehr laden
von

Vorträge (Auszug Forschungs­datenbank)

Different production technology of blood derived products influences differentiation pathway of various cell populations

World Congress of the International Society of Tissue Engineering and Regenerative Medicine (TERMIS), Kyoto, Japan, 07.09.2018

Different production technology of blood derived products influences differentiation pathway of various cell populations

Gordon Research Conference on Extracellular Vesicles, Newry, USA, 21.08.2018

Different production technology of blood derived products influences differentiation pathway of various cell populations

14. World congress of the International cartilage repair society (ICRS) , Macau, China, 12.04.2018

Inhibierung des mTORC1 Signalweges erhält den chondrogenen Phönotyp von OA Chondrozyten

32. Jahreskongress der GOTS, 24.06.2017

Rapamycin preserves the chondrogenic phenotype and supresses cartilage degrading and inflammatory processes in Osteoarthritis

OARSI 2017 World Congress, 28.04.2017

Strategies for Cartilage Regeneration

14. International Life Science Meeting Krems, 05.04.2017

Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells

Osteoarthritis Research Society International World Congress - Amsterdam, Netherlands, 01.04.2016

The role of the mTOR pathway on the chondrogenic differentiation of human amniotic fluid stem cells

Österreichische Gesellschaft für Orthopädie - Vienna,Austria, 30.10.2015

The role of the mTOR pathway on the chondrogenic differentiation of human amniotic fluid stem cells

Tissue Engineering and regenerative Medicine International Society World Kongress - Boston, USA, 11.09.2015

Rapamycin enhances Sox9 expression during chondrogenic differentiation of amniotic fluid stem cells

4th TERMIS World Congress, Boston, USA, 08.09.2015

Mehr laden
von
Zum Anfang der Seite

 

Zum Glossar

Diese Website verwendet Cookies zur Verbesserung Ihrer Nutzererfahrung und für analytische Zwecke zur Optimierung unserer Systeme. Indem Sie auf „OK" klicken bzw. die Website weiter verwenden, stimmen Sie der Cookie-Nutzung zu. Mehr Information zum Datenschutz.

OK